Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acadia Healthcare Company Inc (ACHC) vs HSBC Holdings plc (HSBC) Price & Performance

Acadia Healthcare Company IncTrade
HSBC Holdings plcTrade

Price performance (Past 24H)

Key statistics

Acadia Healthcare Company Inc vs HSBC Holdings plc — how do they compare? Acadia Healthcare Company Inc trades at $31.41 (market cap $2.90B), while HSBC Holdings plc trades at $103.88 (market cap $353.82B). The key difference: HSBC Holdings plc is far larger — about 122× Acadia Healthcare Company Inc's market cap, and HSBC Holdings plc pays a 3.63% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.

ACHCHSBC
Market Cap
$2.90B$353.82B
Sector
HealthTechnology
52-Week High
$35.61$107.86
52-Week Low
$11.68$63.84
Enterprise Value
$5.29B
Dividend Yield
3.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Acadia Healthcare Company Inc

ACHC trades at $31.14, down 2.01% today, with a neutral technical signal and mixed fundamentals. The company reported Q2 2026 EPS of $0.38, beating estimates, but maintains a net loss of -$1.10B for 2025. Analyst consensus is bullish with a $36.00 price target, though ongoing legal investigations and negative profit margins present headwinds. Cash flow from operations improved to $211M in 2026, supporting operational stability amid challenges.

The outlook for ACHC hinges on execution of its turnaround strategy and resolution of legal issues. Upside potential exists if EBITDA guidance improvements and admissions growth persist, but risks from litigation and sustained losses warrant caution. The stock's current valuation at a P/E of 19.82 and P/S of 0.84 may attract value investors if profitability recovers.

HSBC Holdings plc

HSBC's stock trades at $103.88, up 0.54% today, with a bullish technical signal from moving averages and support near $103. Recent Q2 2026 earnings beat expectations with a 7% revenue rise to $19 billion (Defense World, 2026-08-06), and the company announced a $1 billion buyback (WSJ, 2026-08-04). Valuation metrics include a P/E of 14.74 and ROE of 12.44%, reflecting solid profitability.

The outlook is positive due to strong earnings momentum and shareholder returns, but risks include a recent analyst downgrade (Citi to 'neutral' on August 5, 2026) and exposure to Asian market volatility. With 38.1% of analysts rating it a buy, the stock offers growth potential tempered by competitive and regulatory headwinds.

Returns comparison

Trailing returns across standard periods

About Acadia Healthcare Company Inc

Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.

Read more on ACHC

About HSBC Holdings plc

HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.

Read more on HSBC